ZYME NASDAQ
Zymeworks Inc.
1W: +4.8%
1M: -12.0%
3M: +10.5%
YTD: -5.7%
1Y: +102.0%
3Y: +178.1%
5Y: -12.2%
$25.61
+0.50 (+1.99%)
Weekly Expected Move ±6.9%
$21
$22
$24
$26
$27
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$106M
+38.9% ▲
5Y CAGR: +22.2%
Gross Profit
$95M
+24.7% ▲
Operating Income
-$93M
+32.5% ▲
Net Income
-$81M
+33.9% ▲
EPS (Diluted)
$-1.08
+33.3% ▲
EBITDA
$7.6B
+7138.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $27M | $412M | $76M | $76M | $106M |
| YoY Growth | -31.5% | +1446.0% | -81.6% | +0.4% | +38.9% |
| Cost of Revenue | $0 | $0 | $143M | $0 | $11M |
| Gross Profit | $27M | $412M | -$67M | $76M | $95M |
| Gross Margin | 100.0% | 100.0% | -88.1% | 100.0% | 89.8% |
| R&D Expenses | $200M | $209M | $144M | $135M | $137M |
| SG&A Expenses | $43M | $73M | $70M | $62M | $51M |
| Operating Expenses | $242M | $282M | $71M | $213M | $188M |
| Operating Income | -$216M | $131M | -$138M | -$137M | -$93M |
| Operating Margin | -808.2% | 31.6% | -181.6% | -179.7% | -87.3% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$212M | $135M | -$119M | -$117M | -$80M |
| Tax Expense | -$516K | $11M | -$568K | $6M | $1M |
| Net Income | -$212M | $124M | -$119M | -$123M | -$81M |
| Net Margin | -794.0% | 30.1% | -156.1% | -160.8% | -76.6% |
| EPS (Diluted) | $-4.06 | $1.90 | $-1.72 | $-1.62 | $-1.08 |
| EBITDA | -$206M | $142M | -$121M | -$109M | $7.6B |
| Shares Outstanding | 52M | 65M | 69M | 76M | 75M |